Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.69
Ask:
1.70
Spread: 0.01 (0.592%)
Market Cap: €511.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

Form 8.5 (EPT/RI)

6 May 2021 08:27

RNS Number : 7660X
Citigroup Global Markets Limited
06 May 2021
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Globalworth Real Estate Investments Limited

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Globalworth Real Estate Investments Limited

(d) Date dealing undertaken:

5 May 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received(EUR)

Lowest price per unit paid/received(EUR)

Ordinary

Purchase

335

7.3000

7.3000

Ordinary

Sale

335

7.3000

7.3000

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Type e.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

6 May 2021

Contact name:

Damian Flanagan

Telephone number:

+44 (28) 9040-9676

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERZZGGKNVFGMZG
Date   Source Headline
3rd Jun 20263:11 pmRNSFitch investment grade credit rating maintained
22nd May 202611:39 amRNSSatisfaction of employee share awards and TVR
15th May 20267:00 amRNSNotice of AGM and Availability of Annual Report
24th Apr 20265:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20267:00 amRNSAudited Results FY25, Annual Report, Notice of AGM
26th Mar 20261:00 pmRNSS&P - 'BB' Rating affirmed
19th Mar 20267:00 amRNSScrip Dividend Share Reference Price
27th Feb 20267:01 amRNSInterim Dividend & Scrip Alternative
27th Feb 20267:00 amRNSCondensed Unaudited Results for FY 31 Dec 2025
26th Jan 20261:00 pmRNSPartial Bond Redemption
6th Nov 202511:04 amRNSAppointment of Joint CEOs
23rd Sep 20257:00 amRNSHalf-year Report
28th Aug 20257:01 amRNSInterim Dividend Payment
28th Aug 20257:00 amRNSNotice of Interim Results & Prelim Interim Results
26th Jun 20251:41 pmRNSFitch investment grade credit rating maintained
23rd Jun 202512:42 pmRNSResult of AGM
23rd May 202511:45 amRNSBuy back of Shares into Treasury and TVR
15th May 20257:00 amRNSNotice of AGM
1st May 202511:30 amRNSSatisfaction of employee share awards and TVR
25th Apr 20255:35 pmRNSPulbication of Green Allocations Report
23rd Apr 202512:16 pmRNSExtension of secured bank financing
8th Apr 20253:18 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
27th Mar 20257:00 amRNSScrip Dividend Share Reference Price
25th Mar 20257:00 amRNSPublication of Annual Report and Date of AGM
21st Mar 20253:01 pmRNSS&P - revisions to credit rating and outlook
11th Mar 202511:13 amRNSInterim Dividend & Scrip Alternative
11th Mar 20257:00 amRNSCondensed Unaudited Results for FY 31 Dec 2024
18th Oct 20248:01 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
24th Sep 20247:00 amRNSHalf-year Report
19th Sep 20247:00 amRNSScrip Dividend Share Reference Price
16th Sep 20243:54 pmRNSHolding(s) in Company
30th Aug 20247:01 amRNSInterim Dividend & Scrip Alternative
30th Aug 20247:00 amRNSNotice of Interim Results & Prelim Interim Results
6th Aug 20244:10 pmRNSChange of Registered Office
18th Jul 20244:35 pmRNSResults of Tender Offers
11th Jul 20248:15 amRNSLaunch of Tender Offers for Bonds & Trading Updat
1st Jul 202412:01 pmRNSCredit Rating & Change of name of nomad
17th Jun 202410:18 amRNSResult of AGM
31st May 20243:03 pmRNSLogistics Sale Closing & Mandatory Bond Redemption
15th May 202410:14 amRNSNotice of AGM
7th May 202412:21 pmRNSBuyback of shares into treasury and TVR
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.